Lite Strategy, Inc. (LITS)
NASDAQ: LITS · Real-Time Price · USD
1.220
-0.050 (-3.94%)
Oct 12, 2026, 4:00 PM EDT - Market closed
Lite Strategy Market Cap
Lite Strategy has a market cap or net worth of $37.1 million as of October 12, 2026. It is the 32,564th most valuable company in the world and the 4,866th biggest in the United States. Its market cap has decreased by 57.89% in one year.
Market Cap
37.10M
Enterprise Value
31.39M
1-Year Change
-57.89%
Global Rank
Country Rank
#4,866 United States
Category
ChartMarket Cap Chart
Since December 18, 2003, Lite Strategy's market cap has decreased from $424.10M to $37.10M, a decrease of -91.25%. That is a compound annual growth rate of -10.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 37.10M | -23.66% |
| Dec 31, 2025 | 48.60M | 196.34% |
| Dec 31, 2024 | 16.40M | -57.51% |
| Dec 29, 2023 | 38.60M | 18.77% |
| Dec 30, 2022 | 32.50M | -89.20% |
| Dec 31, 2021 | 301.00M | 1.31% |
| Dec 31, 2020 | 297.10M | 62.62% |
| Dec 31, 2019 | 182.70M | -2.72% |
| Dec 31, 2018 | 187.80M | 141.70% |
| Dec 29, 2017 | 77.70M | 46.60% |
| Dec 30, 2016 | 53.00M | -2.93% |
| Dec 31, 2015 | 54.60M | -40.85% |
| Dec 31, 2014 | 92.30M | -46.40% |
| Dec 31, 2013 | 172.20M | 580.63% |
| Dec 31, 2012 | 25.30M | 105.69% |
| Dec 30, 2011 | 12.30M | 73.24% |
| Dec 31, 2010 | 7.10M | -86.19% |
| Dec 31, 2009 | 51.40M | - |
| Dec 31, 2008 | 51.40M | -74.17% |
| Dec 31, 2007 | 199.00M | 2.58% |
| Dec 29, 2006 | 194.00M | -45.49% |
| Dec 30, 2005 | 355.90M | -30.12% |
| Dec 31, 2004 | 509.30M | -23.48% |
| Dec 31, 2003 | 665.60M | 56.94% |
| Dec 18, 2003 | 424.10M | - |
View and export this data all the way back to 2003. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grace Therapeutics | 43.75M |
| Veru Inc. | 41.94M |
| Filana Therapeutics | 39.46M |
| Metagenomi Therapeutics | 37.78M |
| Impact BioMedical | 36.31M |
| GridAI Technologies | 35.19M |
| Actinium Pharmaceuticals | 34.59M |
| BriaCell Therapeutics | 34.21M |